AI-generated summary
This review summarizes the literature on bright-light therapy for mood disorders, covering its established use in seasonal affective disorder and its evidence in other conditions such as chronic, antepartum, premenstrual and bipolar depression. The authors describe the underlying circadian and seasonal biology, including the suprachiasmatic nucleus, melatonin and serotonin. They note that data for non-seasonal depression are promising but that further systematic studies are still warranted.
- Who or what was studied
- Individuals with seasonal affective disorder and other mood disorders, including chronic, antepartum, premenstrual and bipolar depression, and sleep-wake disturbances
- Limits stated in the abstract
- The abstract states that data on non-seasonal depression are promising but that further systematic studies are still warranted.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on karger.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.